UNSPSC 51386609: Hydrocortisone/lidocaine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE200. This VA Drug Class (DE200) classifies this compound as belonging to the group ANTI-INFLAMMATORY, TOPICAL.

UNSPSC 51386609 Hydrocortisone/lidocaine is a Commodity code for pharmaceutical products, though the recent state and local procurement activity under this code shows a significant mismatch between the nominal scope and what is actually being solicited. Seminole County, Florida posted IFB 60459723LAS seeking to procure naloxone and drug deactivation systems, neither of which falls within the hydrocortisone/lidocaine pharmaceutical category. The opportunity reflects community health and harm-reduction initiatives rather than the steroid-anesthetic combination the code nominally describes. The issuing body is a county health procurement office; no other recent state and local opportunities under this code are present in the available data, making it difficult to characterize a broader issuing-body mix or repeat-buyer pattern.

The single available opportunity is geographically concentrated in Florida (Seminole County). The IFB, posted June 30, 2026, with a response deadline of July 26, 2023, calls for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Bidders must submit electronically, include all shipping and delivery costs, and comply with drug-free workplace certification, E-Verify, and federal compliance requirements tied to potential FEMA funding. The contract carries a two-year initial term with a one-year renewal option and includes a three-month probationary termination period. Given the sparse recent activity and the categorical misalignment between the code's nominal definition and the naloxone procurement actually posted, this code shows limited relevant current opportunity for vendors specializing in hydrocortisone/lidocaine products.